United Therapeutics CEO Martine Rothblatt disposes of 9,500 shares for $4.79 million
UTHR•Rothblatt reports option exercise and trust share sale
- United Therapeutics Chairperson and CEO Martine A. Rothblatt reported option exercise for 9,500 shares at USD 135.42.
- Family trust sold 9,500 shares in multiple trades at about USD 500.63 to USD 508.69.
- Trust holdings ended at 324,443 shares following the transactions on Aug. 17.
